A study now finds early memory impairment in a mouse model of amyloid β43 (Aβ43)-overproducing familial Alzheimer's disease and suggests that this overlooked amyloidogenic Aβ species contributes to pathology.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease
Acta Neuropathologica Communications Open Access 18 September 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hardy, J. & Selkoe, D.J. Science 297, 353–356 (2002).
Hardy, J. J. Neurochem. 110, 1129–1134 (2009).
Saito, T. et al. Nat. Neurosci. 14, 1023–1032 (2011).
De Strooper, B., Vassar, R. & Golde, T. Nat. Rev. Neurol. 6, 99–107 (2010).
Jin, M. et al. Proc. Natl. Acad. Sci. USA 108, 5819–5824 (2011).
Noguchi, A. et al. J. Biol. Chem. 284, 32895–32905 (2009).
Bentahir, M. et al. J. Neurochem. 96, 732–742 (2006).
De Strooper, B. et al. EMBO J. 14, 4932–4938 (1995).
Kumar-Singh, S. et al. Hum. Mutat. 27, 686–695 (2006).
Welander, H. et al. J. Neurochem. 110, 697–706 (2009).
Qi-Takahara, Y. et al. J. Neurosci. 25, 436–445 (2005).
Martins, I.C. et al. EMBO J. 27, 224–233 (2008).
Jarrett, J.T., Berger, E.P. & Lansbury, P.T. Jr. Biochemistry 32, 4693–4697 (1993).
Takami, M. et al. J. Neurosci. 29, 13042–13052 (2009).
De Strooper, B. EMBO Rep. 8, 141–146 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Bart De Strooper is a consultant for Janssen Pharmaceutica, Envivo Pharmaceuticals and Remynd NV. He also receives research funding from Janssen Pharmaceutica.
Rights and permissions
About this article
Cite this article
Benilova, I., De Strooper, B. An overlooked neurotoxic species in Alzheimer's disease. Nat Neurosci 14, 949–950 (2011). https://doi.org/10.1038/nn.2871
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.2871
This article is cited by
-
Compromised MAPK signaling in human diseases: an update
Archives of Toxicology (2015)
-
Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease
Acta Neuropathologica Communications (2014)